Navigation Links
CuraGen Announces Top-Line Phase II Results on Velafermin
Date:10/11/2007

en.com" target="_new">http://www.curagen.com.

Safe Harbor

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to the advancement of the belinostat and CR011- vcMMAE programs and the projected timing for updates on the CuraGen's clinical trial results may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as "anticipate," "believe," "could," "could increase the likelihood," "estimate," "expect," "intend," "is planned," "may," "should," "will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms. Such forward-looking statements involve known and unknown risks, uncertainties and other factors including the risk that any one or more of CuraGen's drug development programs will not proceed as planned for technical, scientific or commercial reasons or due to patient enrollment issues or based on new information from nonclinical or clinical studies or from other sources, the success of competing products and technologies, CuraGen's stage of development as a biopharmaceutical company, government regulation and healthcare reform, technological uncertainty and product development risks, product liability exposure, uncertainty of additional funding, CuraGen's history of incurring losses and the uncertainty of achieving profitability, reliance on research collaborations and strategic alliances, competition, patent infringement claims against CuraGen's products, processes and technologies, CuraGen's ability to protect its patents and proprietary rights and uncertainties relating to commercialization rights, as well as those risks, uncertainties and factors referred to in the Company's Quarterly Report on Form 10-Q for the quarter
'/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015 The saturated European market ... the rising incidence of preterm births. This trend is ... unit (NICU) devices but also skilled and trained professionals ... Frost & Sullivan, Analysis of the Western European Infant ... of $151.5 million in 2014 and estimates this to ...
(Date:4/20/2015)... WASHINGTON , April 21, 2015  Following is ... Bureau: LIFESAVING MEDICINE ... world,s most important medicines — insulin —became available for ... of millions of people suffering from diabetes. Insulin is ... in the processing of carbohydrates in the human body. ...
(Date:4/20/2015)... YORK , April 20, 2015 This report ... by the following Segments: Toxicology Testing (In-Vivo, & In-Vitro), and ... US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology:Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 2Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 3U.S. Census Bureau Daily Feature for April 21 2World ADME-Toxicology Testing Industry 2World ADME-Toxicology Testing Industry 3World ADME-Toxicology Testing Industry 4World ADME-Toxicology Testing Industry 5World ADME-Toxicology Testing Industry 6World ADME-Toxicology Testing Industry 7World ADME-Toxicology Testing Industry 8World ADME-Toxicology Testing Industry 9World ADME-Toxicology Testing Industry 10World ADME-Toxicology Testing Industry 11World ADME-Toxicology Testing Industry 12World ADME-Toxicology Testing Industry 13World ADME-Toxicology Testing Industry 14World ADME-Toxicology Testing Industry 15World ADME-Toxicology Testing Industry 16World ADME-Toxicology Testing Industry 17World ADME-Toxicology Testing Industry 18World ADME-Toxicology Testing Industry 19
(Date:4/21/2015)... NC (PRWEB) April 21, 2015 A ... survival rates among patients with peritoneal cancers like mesothelioma ... Surviving Mesothelioma has just posted the results of the ... . , Doctors at North Hampshire Hospital in ... with peritoneal malignancies such as mesothelioma between ...
(Date:4/21/2015)... April 21, 2015 Atlantic Information ... launch of Medicare-Medicaid Dual Eligibles Database, a brand-new, ... care provided to the more than 9 million ... for more than $300 billion in annual health ... the same team that also creates the industry-leading ...
(Date:4/21/2015)... Now, busy Diet Doc clients can bolster their metabolism ... breakfast omelets. Like Diet Doc’s other pre-packaged diet meals, ... are delivered directly to their door. Patients can choose from ... only appeal to the taste buds, but ensure that dieters ... low carbohydrate meals. , One of the only medical ...
(Date:4/21/2015)... TX (PRWEB) April 21, 2015 ... is actively involved in various components of breast ... fields. , "Breast reconstruction research continues ... mastectomy. Despite recent advances, many unanswered questions ... provide patients with optimal results," says Dr. Oscar ...
(Date:4/21/2015)... April 21, 2015 The Science Museum of ... special addition to its Lunch Break Science program. On Wednesday, ... Quarks! – taking guests from the subatomic world of quantum ... The Museum invites members of the community to grab lunch ... Lab physicist. Guests will delve into the nucleus and dissect ...
Breaking Medicine News(10 mins):Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 3Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Quarks and Forks at the Science Museum of Virginia 2
... likely to bear an underweight child, but some women ... genetic susceptibility.// The finding could help medicine better determine ... said they were not recommending at this point that ... ,"Our data demonstrate that a subgroup of ...
... the UK’s biggest killer, accounting for one in four ... key issue is that the diversity of lung disease ... have specialists who deal only in one disorder, chest ... obstructive pulmonary disorder(COPD), asthma, pneumonia, cystic fibrosis and sleep ...
... found that butterbur extract is an effective antihistamine without ... contains an active biochemical agent,// otherwise it would not ... might react with other medications. ,It was ... patients either butterbur extract tablets or the usually used ...
... Millions of Americans have been drinking tap water contaminated ... to disinfect drinking water.// When it is added to ... farms or lawns, however, it can form compounds such ... study released by the Environmental Working Group and Public ...
... save 40,000 more lives each year worldwide if more people ... took it, doctors said.// An analysis of nearly 300 ... to prevent blood clots confirmed that aspirin reduces heart attacks ... the people who could benefit from aspirin and anti-platelet therapy ...
... has launched Hyalosyn (sodium hyaluronate), an intra-articular injection that ... suffering from severe osteoarthritis. Osteoarthritis is a widely prevalent ... the age of 45 are estimated to show signs ... of disability in people above the age of 65. ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: